NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1053376954 DO
Verify on CMS → Navtika Desai, DO
Endocrinology, Diabetes & Metabolism Physician in Hillsborough, New Jersey.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,871 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
416
Medicare Part D claims · 63 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
0%
generic claims · 61% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$60.8K
100 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Navtika Desai, DO filed 416 Medicare Part D claims in 2023 as an Endocrinology, Diabetes & Metabolism Physician in Hillsborough, New Jersey, prescribing 0% generic.
- 416
- Part D claims, 2023
- 0%
- generic prescribing
- $60.8K
- industry payments (Sunshine Act)
- ≥62nd
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Navtika Desai, DO
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1053376954), first enumerated 04/20/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 416 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- Reported
Industry payment transparency
$60.8K in reported industry payments (100 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1053376954 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-LEGACY · TAX-MID · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1053376954
- ENUM-LEGACY 2006
- TAX-MID 8K Endocrinology, Diabetes
- RX-LIGHT 416
- BOOK-THIN 324 in New Jersey
- PHOTO-ENUM Ursula Kaiser · 2006
Navtika Desai, DO's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
416 ≥ 62nd percentile 62% of 1,370,886 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2023
◑
Board-eligible specialty (heuristic, not verified)
Navtika Desai, DO practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Navtika Desai, DO?
Quality data not reportedPrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
416 84% vs specialty avg
Specialty distribution in New Jersey
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among New Jersey providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1053376954 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | DO |
| Gender | Female |
| NPI Issued | 04/20/2006 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Navtika Desai, DO. Source: openpaymentsdata.cms.gov.
Total received
$60.8K
Largest payer
Novo Nordisk Inc
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
Navtika Desai, DO - brand share 61.0%
Endocrinology, Diabetes & Metabolism Physician average
61% brand-name claims vs 0% generic, on 416 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
416
Total Claims
$205K
Total Drug Cost
63
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,071
- Total Day Supply
- 31,946
- Brand vs Generic
- 61% brand / 0% generic
- Brand Drug Cost
- $194K
Patient Demographics
- Average Patient Age
- 71.0 years
- Avg HCC Risk Score
- 0.80
- Gender Split
- 62% female / 38% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Navtika Desai, DO prescribes most
Top Medicare Part D drugs by claim count, 2023
- Synthroid
Synthroid
67 claims
- Levothyroxine Sodium
Levothyroxine Sodium
48 claims
- Ozempic
Ozempic
29 claims
- Unithroid 26
Unithroid
26 claims
- Jardiance 24
Jardiance
24 claims
- Metformin Hcl 21
Metformin Hcl
21 claims
- Trulicity 21
Trulicity
21 claims
- Atorvastatin Calcium 16
Atorvastatin Calcium
16 claims
| Drug | Claims |
|---|---|
| Synthroid Levothyroxine Sodium | 67 |
| Levothyroxine Sodium | 48 |
| Ozempic Semaglutide | 29 |
| Unithroid Levothyroxine Sodium | 26 |
| Jardiance Empagliflozin | 24 |
| Metformin Hcl | 21 |
| Trulicity Dulaglutide | 21 |
| Atorvastatin Calcium | 16 |
| Humalog Kwikpen U-100 Insulin Lispro | 16 |
| Metformin Hcl Er Metformin Hcl | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in NJ →
All providers in New Jersey →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Navtika Desai, DO fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
7,871
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider
Navtika Desai, DO's 416 claims are below the specialty average of 2,639.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Desai, both outside New Jersey so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as Desai.
One of 324 Endocrinology, Diabetes & Metabolism Physician providers enrolled in New Jersey, 5 are shown here.
Dr. Alice Abraham
M.D.
Englewood, NJ
Dr. Sonoo Advani
M.D.
West Orange, NJ
Dr. Karen Agersborg
DO
Cape May Court House, NJ
Dr. Richard Agrin
MD
New Brunswick, NJ
Dr. Sana Ahsun
MD
Piscataway, NJ
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Navtika Desai, DO's specialty? ▼
Navtika Desai, DO specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Hillsborough, New Jersey. Credentials: DO.
How much does Navtika Desai, DO prescribe under Medicare Part D? ▼
In 2023, Navtika Desai, DO wrote 416 Medicare Part D claims totaling $205K in drug costs for 63 beneficiaries.
Where is Navtika Desai, DO located? ▼
Navtika Desai, DO is located at 105 RAIDER BLVD, Hillsborough, NJ, 08844. Phone: (908) 829-4244.
What is Navtika Desai, DO's NPI number? ▼
Navtika Desai, DO's National Provider Identifier (NPI) is 1053376954, issued on 04/20/2006.
Does Navtika Desai, DO prescribe more brand-name or generic drugs? ▼
Navtika Desai, DO's prescribing is 61% brand-name and 0% generic drugs by claim count, with $194K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 7,871 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Navtika Desai, DO prescribe most often? ▼
Based on 2023 Medicare Part D data, Navtika Desai, DO's most frequently prescribed drugs include Synthroid, Levothyroxine Sodium, Ozempic. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Navtika Desai, DO accept Medicare? ▼
Navtika Desai, DO appears in CMS Medicare data with 416 Part D claims and 63 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Navtika Desai, DO's credentials? ▼
Navtika Desai, DO's NPI is 1053376954 with credentials DO. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.